See also this year's filing and all EDGAR filings for this company.
PDF Report 0001297184_2023_Amphastar_Pharmaceuticals_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001297184, Amphastar Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 378,319,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 238,266,000 |
| 3 | remainder_Assets | 125,402,000 |
| 4 | LiabilitiesCurrent | 94,862,000 |
| 5 | LiabilitiesNoncurrent | 38,259,000 |
| 6 | remainder_Liabilities | 80,208,000 |
| 7 | CostOfGoodsAndServicesSold | 250,127,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 45,061,000 |
| 9 | ResearchAndDevelopmentExpense | 74,771,000 |
| 10 | remainder_Expenses | 45,008,000 |
| 11 | remainder_Revenues | 498,987,000 |
| 12 | remainder_NetIncome | 7,366,000 |
| 13 | remainder_ComprehensiveNetIncome | -1,859,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 741,987,000 |
| 1 | Liabilities | 213,329,000 |
| 2 | Expenses | 414,967,000 |
| 3 | Revenues | 498,987,000 |
| 4 | StockholdersEquity | 528,658,000 |
| 5 | NetIncome | 91,386,000 |
| 6 | ComprehensiveNetIncome | 90,456,500 |
| 7 | BaseVar | 939,247,500 |
| 8 | EconomicCapitalRatio | 2.09 |
Edgar->Model Mapping
Feature Distribution
Change over Time
